series-b
Stage
1
Investors
About
Revatis develops and supplies multipotent adult mesenchymal stem cells derived from minimally invasive muscle micro-biopsies for use in regenerative medicine and cell therapy in both human and veterinary applications.
Explore Revatis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.